Teva, Glaxo Settle Suit Over Generic Lamictal
Teva Pharmaceutical and GlaxoSmithKline have settled their patent litigation over Glaxo's Lamictal with a deal under which Teva will be allowed to launch an exclusive generic version later this year....To view the full article, register now.
Already a subscriber? Click here to view full article